— European Journal of Pharmacology molecular pharmacology Molecular Pharmacology Section 267 (1994) 349-351 Author index Ala-Uotila, S., see Marjamaki, A. (267) 117 Concas, A., Santoro, G., Mascia, M.P., Maciocco, E., Dazzi, L. and Alfonso, A., Botana, M.A., Vieytes, M.R. and Botana, L.M. Biggio, G. Functional characterization of the Na*-H* exchanger in rat mast Effects of propofol, pentobarbital and alphaxalone on t- cells: crosstalks between different kinase pathways (267) 289 [*°S]butylbicyclophosphorothionate binding in rat cerebral cortex Andersen, P.H., see Pedersen, U.B. (267) 85 (267) 207 Animati, F., see Feriotto, G. (267) 143 Aoyama, T., see Hattori, R. (267) R1 Dalpiaz, A., see Borea, P.A. (267) 55 Arcamone, F., see Feriotto, G. (267) 143 Daviaud, D., see Larrouy, D. (267) 225 Augenlicht, L.H., see Jarry, A. (267) 95 Dazzi, L., see Concas, A. (267) 207 DeBernardis, J.F., see Hancock, A.A. (267) 49 Barden, J.A., see Potter, E.K. (267) 253 De Blas, A.L., see Ruano, D. (267) 121 Baron, B.M., see McClue, S.J. (267) 185 Dennis, M., see Ng, G.YK. (267) 7 Basile, A.S., see Harris, B.D. (267) 269 Devaud, L.L. and Morrow, A.L. Effects of chronic ethanol administration on [*H]zolpidem bind- Bazan, A., see Fraeyman, N. (267) 63 Beaufort, P., see Chatelain, P. (267) 151 ing in rat brain (267) 243 Bidlack, J.M., see Joseph, D.B. (267) 1 Dewinkeleer, P., see Chatelain, P. (267) 151 Biggio, G., see Concas, A. (267) 207 Dimmeler, S., MeBmer, U.K., Tiegs, G. and Briine, B. Boel, E., see Thomsen, C. (267) 77 Modulation of glyceraldehyde-3-phosphate dehydrogenase in Borea, P.A., Varani, K., Dalpiaz, A., Capuzzo, A., Fabbri, E. and Salmonella abortus equi \ipopolysaccharide-treated mice (267) 105 IJzerman, A.P. Donnelly, L.E., see Boyd, R.S. (267) 161 Full and partial agonistic behaviour and thermodynamic binding Dutta, A.K., see Madras, B.K. (267) 167 parameters of adenosine A, receptor ligands (267) 55 Botana, L.M., see Alfonso, A. (267) 289 Egan, R.W., see West, Jr., R.E. (267) 343 Botana, M.A., see Alfonso, A. (267) 289 Eizawa, H., see Hattori, R. (267) R1 Bouvier, M., see Ng, G. YK. (267) 7 Evens, J.F., see Charleson, S. (267) 275 Boyd, R.S., Donnelly, L.E. and MacDermot, J. Loss of responses to bradykinin, ATP or carbachol follows deple- Fabbri, E., see Borea, P.A. (267) 55 tion of a shared pool of calcium ions (267) 161 Feriotto, G., Ciucci, A., Mischiati, C., Animati, F., Lombardi, P., Briine, B., see Dimmeler, S. (267) 105 Giacomini, P., Arcamone, F. and Gambari, R. Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibi- Cameron, B.-R., see Taverna, F.A. (267) R3 tion by distamycin and two novel distamycin analogues (267) 143 Capuzzo, A., see Borea, P.A. (267) 55 Fisher, A., see Gurwitz, D. (267) 21 Caron, M., see Ng, G.YK. (267) 7 Fletcher, E.J., Church, J. and MacDonald, J.F. Haloperidol blocks voltage-activated Ca?* channels in hippocam- Carvalho, C.M., see Santos, D.L. (267) 307 Charleson, S., Evans, J.F., Léger, S., Perrier, H., Prasit, P., Wang, Z. pal neurones (267) 249 and Vickers, P.J. Fraeyman, N., Bazan, A. and Vanscheeuwijck, P. Structural requirements for the binding of fatty acids to 5-lipo- Thermodynamic analysis of isoproterenol binding to B-adreno- xygenase-activating protein (267) 275 ceptors in rat lung membranes (267) 63 Chatelain, P., Dewinkeleer, P., Beaufort, P., Meysmans, L. and Fraser, C.M., see Gurwitz, D. (267) 21 Clinet, M. Freedman, S.B., see Patel, S. (267) 329 Characterization of the binding of [*HJSR 33805 to the slow Freedman, S.B., see Smith, A.J. (267) 215 Ca?* channel in rat heart sarcolemmal membrane (267) 151 Fulcrand, P., see Lallement, J.-C. (267) 297 Chen, J.-S., see Wang, C.-N. (267) 33 Chen, X., Nishimura, J., Hasna, J., Kobayashi, S., Shikasho, T. and Galleyrand, J.-C., see Lallement, J.-C. (267) 297 Kanaide, H. Gambari, R., see Feriotto, G. (267) 143 Protein kinase C and protein kinase A regulate the expression of George, S.R., see Ng, G.YK. (267) 7 angiotensin II] receptor mRNA in smooth muscle cells (267) 175 Giacomini, P., see Feriotto, G. (267) 143 Church, J., see Fletcher, E.J. (267) 249 Gurwitz, D., Haring, R., Heldman, E., Fraser, C.M., Manor, D. and Ciucci, A., see Feriotto, G. (267) 143 Fisher, A. Clark, M.A., see West, Jr., R.E. (267) 343 Discrete activation of transduction pathways associated with Clinet, M., see Chatelain, P. (267) 151 acetylcholine m1 receptor by several muscarinic ligands (267) 21 350 Author index / European Journal of Pharmacology - Molecular Pharmacology Section 267 (1994) 349-351 Hale, C.C., see Shannon, T.R. (267) 233 Lallement, J.-C., Galleyrand, J.-C., Lima-Leite, A.-C., Fulcrand, P. Hampson, D.L., see Taverna, F.A. (267) R3 and Martinez, J. Hancock, A.A., Surber, B.W., Rotert, G., Thomas, S., Tasker, A.S., Gastrin,, and the C-terminal octapeptide of cholecystokinin are Sorensen, B.K., Vodenlich, A.D., Opgenorth, T.J., Kerkman, D_J. differently coupled to G-proteins in guinea-pig brain membranes and DeBernardis, J.F. (267) 297 [7HJA-81988, a potent, selective, competitive antagonist radioli- Larrouy, D., Remaury, A., Daviaud, D. and Lafontan, M. gand for angiotensin AT, receptors (267) 49 Coupling of inhibitory receptors with G,-proteins in hamster Hansen, A., see Pedersen, U.B. (267) 85 adipocytes: comparison between adenosine A, receptor and a,- Haring, R., see Gurwitz, D. (267) 21 adrenoceptor (267) 225 Harris, B.A., see McClue, S.J. (267) 185 Léger, S., see Charleson, S. (267) 275 Harris, B.D., Moody, E.J., Basile, A.S. and Skolnick, P. Lima-Leite, A.-C., see Lallement, J.-C. (267) 297 Volatile anesthetics bidirectionally and stereospecifically modu- Lombardi, P., see Feriotto, G. (267) 143 late ligand binding to GABA receptors (267) 269 Lombet, A. and Spedding, M. Hashimoto, K., see Hirasawa, A. (267) 71 Differential effects of non-peptidic tachykinin receptor antago- Hasna, J., see Chen, X. (267) 175 nists on Ca?* channels (267) 113 Hattori, R., Inoue, R., Sase, K., Eizawa, H., Kosuga, K., Aoyama, T., Lopes, M.C., see Santos, D.L. (267) 307 Masayasu, H., Kawai, C., Sasayama, S. and Yui, Y. Luo, D. and Vincent, S.R. Preferential inhibition of inducible nitric oxide synthase by ebse- Metalloporphyrins inhibit nitric oxide-dependent cGMP forma- len (267) R1 tion in vivo (267) 263 Heldman, E., see Gurwitz, D. (267) 21 Helmeste, D.M. and Tang, S.W. MacDermot, J., see Boyd, R.S. (267) 161 Kinase inhibitors compete with imipramine for binding and inhi- MacDonald, J.F., see Fletcher, E.J. (267) 249 bition of serotonin transport (267) 239 MacDonald, J.F., see Taverna, F.A. (267) R3 Herzog, H., see Potter, E.K. (267) 253 Machado, A., see Ruano, D. (267) 121 Hirasawa, A., Hashimoto, K. and Tsujimoto, G. Maciocco, E., see Concas, A. (267) 207 Distribution and developmental change of vasopressin V,, and Madras, B.K., Reith, M.E.A., Meltzer, P.C. and Dutta, A.K. V, receptor mRNA in rats (267) 71 O-526, a piperidine analog of GBR 12909, retains high affinity Hirouchi, M., see Ichida, T. (267) 43 for the dopamine transporter in monkey caudate-putamen (267) Hopfer, U., see Jarry, A. (267) 95 167 Mailleux, P. and Vanderhaeghen, J.-J. Ichida, T., Hirouchi, M., Mizutani, H., Narihara, R. and Kuriyama, 5-9-Tetrahydrocannabinol regulates substance P and enkephalin K. mRNAs levels in the caudate-putamen (267) R1 Association and agonistic action of DN-2327, a novel isoindoline Manor, D., see Gurwitz, D. (267) 21 derivative, on GABA , receptor in brain (267) 43 Marjamaki, A., Pohjanoksa, K., Ala-Uotila, S., Sizmann, D., Oker- Ichimura, M., see Nonaka, H. (267) 335 Blom, C., Kurose, H. and Scheinin, M. IJzerman, A.P., see Borea, P.A. (267) 55 Similar ligand binding in recombinant human a,C2-adrenocep- Inoue, R., see Hattori, R. (267) R1 tors produced in mammalian, insect and yeast cells (267) 117 Martinez, J., see Lallement, J.-C. (267) 297 Masayasu, H., see Hattori, R. (267) R1 Jacobsson, G., see Meister, B. (267) 323 Mascia, M.P., see Concas, A. (267) 207 Jarry, A., Merlin, D., Velcich, A., Hopfer, U., Augenlicht, L.H. and McCloskey, M.J.D., see Potter, E.K. (267) 253 Laboisse, C.L. McClue, S.J., Baron, B.M. and Harris, B.A. Interferon-y modulates cAMP-induced mucin exocytosis without Activation of G; protein by peptide structures of the muscarinic affecting mucin gene expression in a human colonic goblet cell line (267) 95 M, receptor second intracellular loop (267) 185 Meister, B. and Jacobsson, G. Jensen, A.A., see Pedersen, U.B. (267) 85 Joseph, D.B. and Bidlack, J.M. Segment-specific expression of messenger RNA encoding for a glutamate transporter by renal tubule cells (267) 323 The x-opioid receptor expressed on the mouse lymphoma cell Meltzer, P.C., see Madras, B.K. (267) 167 line R1.1 contains a sulfhydryl group at the binding site (267) 1 Merlin, D., see Jarry, A. (267) 95 MeBmer, U.K., see Dimmeler, S. (267) 105 Kanaide, H., see Chen, X. (267) 175 Meysmans, L., see Chatelain, P. (267) 151 Kase, H., see Nonaka, H. (267) 335 Mischiati, C., see Feriotto, G. (267) 143 Kawai, C., see Hattori, R. (267) R1 Miyamoto, K.-i., Kurita, M., Ohmae, S., Sakai, R., Sanae, F. and Kerkman, D.J., see Hancock, A.A. (267) 49 Takagi, K. Khan, Z., see Ruano, D. (267) 121 Selective tracheal relaxation and phosphodiesterase-IV inhibition Kiang, J.G. by xanthine derivatives (267) 317 Corticotropin-releasing factor increases [Ca**], via receptor- Mizutani, H., see Ichida, T. (267) 43 mediated Ca** channels in human epidermoid A-431 cells (267) Moody, E.J., see Harris, B.D. (267) 269 135 Morrow, A.L., see Devaud, L.L. (267) 243 Kobayashi, S., see Chen, X. (267) 175 Mouillac, B., see Ng, G.YK. (267) 7 Kosuga, K., see Hattori, R. (267) R1 Myers, J., see West, Jr., R.E. (267) 343 Kurita, M., see Miyamoto, K.-i. (267) 317 Kuriyama, K., see Ichida, T. (267) 43 Narihara, R., see Ichida, T. (267) 43 Kurose, H., see Marjamaki, A. (267) 117 Ng, G.YK., Mouillac, B., George, $.R., Caron, M., Dennis, M., Bouvier, M. and O’Dowd, B.F. Laboisse, C.L., see Jarry, A. (267) 95 Desensitization, phosphorylation and palmitoylation of the hu- Lafontan, M., see Larrouy, D. (267) 225 man dopamine D, receptor (267) 7 Author index / European Journal of Pharmacology — Molecular Pharmacology Section 267 (1994) 349-351 Nishimura, J., see Chen, X. (267) 175 Shiao, M.-S., see Wang, C.-N. (267) 33 Nonaka, H., Ichimura, M., Takeda, M., Nonaka, Y., Shimada, J., Shikasho, T., see Chen, X. (267) 175 Suzuki, F., Yamaguchi, K. and Kase, H. Shimada, J., see Nonaka, H. (267) 335 KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methyl- Shine, J., see Potter, E.K. (267) 253 xanthine), a potent and selective adenosine A, receptor antago- Siegel, M.1., see West, Jr., R.E. (267) 343 nist (267) 335 Sizmann, D., see Marjamaki, A. (267) 117 Nonaka, Y., see Nonaka, H. (267) 335 Skolnick, P., see Harris, B.D. (267) 269 Norby, B., see Pedersen, U.B. (267) 85 Smith, A.J., Patel, S. and Freedman, S.B. Characterisation of CCK, receptors on GH, pituitary cells: receptor activation is linked to Ca** mobilisation (267) 215 O’Dowd, B.F., see Ng, G. YK. (267) 7 Ohmae, S., see Miyamoto, K.-i. (267) 317 Sorensen, B.K., see Hancock, A.A. (267) 49 Okamoto, K., see Sakuta, H. (267) 281 Spedding, M., see Lombet, A. (267) 113 Oker-Blom, C., see Marjamaki, A. (267) 117 Suhr-Jessen, P., see Pedersen, U.B. (267) 85 Opgenorth, T.J., see Hancock, A.A. (267) 49 Surber, B.W., see Hancock, A.A. (267) 49 Suzdak, P.D., see Thomsen, C. (267) 77 Suzuki, F., see Nonaka, H. (267) 335 Patel, S. and Freedman, S.B. The muscarinic receptor agonist L-658,903 modulates the in vivo Takagi, K., see Miyamoto, K.-i. (267) 317 accumulation of inositol monophosphates in mouse brain (267) Takeda, M., see Nonaka, H. (267) 335 329 Tandai, M., see Sakuta, H. (267) 281 Patel, S., see Smith, A.J. (267) 215 Tang, S.W., see Helmeste, D.M. (267) 239 Pedersen, U.B., Norby, B., Jensen, A.A., Schigdt, M., Hansen, A., Tasker, A.S., see Hancock, A.A. (267) 49 Suhr-Jessen, P., Scheideler, M., Thastrup, O. and Andersen, P.H. Taverna, F.A., Cameron, B.-R., Hampson, D.L., Wang, L.-Y. and Characteristics of stably expressed human dopamine D,, and D,, MacDonald, J.F. receptors: Atypical behavior of the dopamine D,,, receptor (267) Sensitivity of AMPA receptors to pentobarbital (267) R3 85 Thastrup, O., see Pedersen, U.B. (267) 85 Perrier, H., see Charleson, S. (267) 275 Thomas, S., see Hancock, A.A. (267) 49 Pohjanoksa, K., see Marjamaki, A. (267) 117 Thomsen, C., Boel, E. and Suzdak, P.D. Potter, E.K., Barden, J.A., McCloskey, M.J.D., Selbie, L.A., Tseng, Actions of phenylglycine analogs at subtypes of the metabotropic A., Herzog, H. and Shine, J. glutamate receptor family (267) 77 A novel neuropeptide Y analog, N-acetyl [Leu”*,Leu*' Jneuro- Tiegs, G., see Dimmeler, S. (267) 105 peptide Y-(24—36), with functional specificity for the presynaptic Tokola, H., Salo, K., Vuolteenaho, O. and Ruskoaho, H. (Y,) receptor (267) 253 Basal and acidic fibroblast growth factor-induced atrial natri- Prasit, P., see Charleson, S. (267) 275 uretic peptide gene expression and secretion is inhibited by staurosporine (267) 195 Reith, M.E.A., see Madras, B.K. (267) 167 Tseng, A., see Potter, E.K. (267) 253 Remaury, A., see Larrouy, D. (267) 225 Tsujimoto, G., see Hirasawa, A. (267) 71 Rotert, G., see Hancock, A.A. (267) 49 Ruano, D., Khan, Z., De Blas, A.L., Machado, A. and Vitorica, J. Vanderhaeghen, J.-J., see Mailleux, P. (267) R1 Molecular heterogeneity of the type 1 GABA, / benzodiazepine Vanscheeuwijck, P., see Fraeyman, N. (267) 63 receptor complex (267) 121 Varani, K., see Borea, P.A. (267) 55 Ruskoaho, H., see Tokola, H. (267) 195 Velcich, A., see Jarry, A. (267) 95 Vickers, P.J., see Charleson, S. (267) 275 Sakai, R., see Miyamoto, K.-i. (267) 317 Vieytes, M.R., see Alfonso, A. (267) 289 Sakuta, H., Okamoto, K. and Tandai, M. Vincent, S.R., see Luo, D. (267) 263 Atrial natriuretic factor potentiates glibenclamide-sensitive K* Vitorica, J., see Ruano, D. (267) 121 currents via the activation of receptor guanylate cyclase in folli- Vodenlich, A.D., see Hancock, A.A. (267) 49 cle-enclosed Xenopus oocytes (267) 281 Vuolteenaho, O., see Tokola, H. (267) 195 Salo, K., see Tokola, H. (267) 195 Sanae, F., see Miyamoto, K.-i. (267) 317 Wang, C.-N., Chen, J.-S., Shiao, M.-S. and Wang, C.-T. Santoro, G., see Concas, A. (267) 207 Activation of human platelet phospholipases C and A, by various Santos, D.L., Lopes, M.C. and Carvalho, C.M. oxygenated triterpenes (267) 33 Calcium channel blockers inhibit the (Ca? *+ Mg** )-ATPase ac- Wang, C.-T., see Wang, C.-N. (267) 33 tivity and the '**I-calmodulin binding in brain membranes (267) Wang, L.-Y., see Taverna, F.A. (267) R3 307 Wang, Z., see Charleson, S. (267) 275 Sasayama, S., see Hattori, R. (267) R1 West, Jr., R.E., Myers, J., Zweig, A., Siegel, M.1., Egan, R.W. and Sase, K., see Hattori, R. (267) R1 Clark, M.A. Scheideler, M., see Pedersen, U.B. (267) 85 Steroid-sensitivity of agonist binding to pituitary cell line his- Scheinin, M., see Marjamaki, A. (267) 117 tamine H, receptors (267) 343 Schigdt, M., see Pedersen, U.B. (267) 85 Selbie, L.A., see Potter, E.K. (267) 253 Yamaguchi, K., see Nonaka, H. (267) 335 Shannon, T.R. and Hale, C.C. Yui, Y., see Hattori, R. (267) Ri Identification of a 65 kDa endothelin receptor in bovine cardiac sarcolemmal vesicles (267) 233 Zweig, A., see West, Jr., R.E. (267) 343